Javascript must be enabled to continue!
Development and validation of an automated Tomotherapy planning method for cervical cancer
View through CrossRef
Abstract
Purpose
This study aimed to develop an automated Tomotherapy (TOMO) planning method for cervical cancer treatment, and to validate its feasibility and effectiveness.
Materials and Methods
The study enrolled 30 cervical cancer patients treated with TOMO at our center. Utilizing scripting and Python environment within the RayStation (RaySearch Labs, Sweden) treatment planning system (TPS), we developed automated planning methods for TOMO and volumetric modulated arc therapy (VMAT) techniques. The clinical manual TOMO (M-TOMO) plans for the 30 patients were re-optimized using automated planning scripts for both TOMO and VMAT, creating automated TOMO (A-TOMO) and automated VMAT (A-VMAT) plans. we compared it with M-TOMO and A-VMAT plans. The primary evaluated relevant dosimetric parameters and treatment plan efficiency were assessed using the two-sided Wilcoxon signed-rank test for statistical analysis,with a P-value < 0.05 indicating statistical significance.
Results
A-TOMO plans maintained similar target dose uniformity compared to M-TOMO plans, with improvements in target conformity and faster dose drop-off outside the target, and demonstrated significant statistical differences (P+<0.01). A-TOMO plans also significantly outperformed M-TOMO plans in reducing V50Gy, V40Gy, and Dmean for the bladder and rectum, as well as Dmean for the bowel bag, femoral heads, and kidneys (all P+<0.05). Additionally, A-TOMO plans demonstrated better consistency in plan quality. Furthermore, the quality of A-TOMO plans was comparable to or superior than A-VMAT plans. In terms of efficiency, A-TOMO significantly reduced the time required for treatment planning to approximately 20 minutes.
Conclusion
We have successfully developed an A-TOMO planning method for cervical cancer. Compared to M-TOMO plans, A-TOMO plans improved target conformity and reduced radiation dose to OARs. Additionally, the quality of A-TOMO plans was on par with or surpasses that of A-VMAT plans. The A-TOMO planning method significantly improved the efficiency of treatment planning.
Research Square Platform LLC
Title: Development and validation of an automated Tomotherapy planning method for cervical cancer
Description:
Abstract
Purpose
This study aimed to develop an automated Tomotherapy (TOMO) planning method for cervical cancer treatment, and to validate its feasibility and effectiveness.
Materials and Methods
The study enrolled 30 cervical cancer patients treated with TOMO at our center.
Utilizing scripting and Python environment within the RayStation (RaySearch Labs, Sweden) treatment planning system (TPS), we developed automated planning methods for TOMO and volumetric modulated arc therapy (VMAT) techniques.
The clinical manual TOMO (M-TOMO) plans for the 30 patients were re-optimized using automated planning scripts for both TOMO and VMAT, creating automated TOMO (A-TOMO) and automated VMAT (A-VMAT) plans.
we compared it with M-TOMO and A-VMAT plans.
The primary evaluated relevant dosimetric parameters and treatment plan efficiency were assessed using the two-sided Wilcoxon signed-rank test for statistical analysis,with a P-value < 0.
05 indicating statistical significance.
Results
A-TOMO plans maintained similar target dose uniformity compared to M-TOMO plans, with improvements in target conformity and faster dose drop-off outside the target, and demonstrated significant statistical differences (P+<0.
01).
A-TOMO plans also significantly outperformed M-TOMO plans in reducing V50Gy, V40Gy, and Dmean for the bladder and rectum, as well as Dmean for the bowel bag, femoral heads, and kidneys (all P+<0.
05).
Additionally, A-TOMO plans demonstrated better consistency in plan quality.
Furthermore, the quality of A-TOMO plans was comparable to or superior than A-VMAT plans.
In terms of efficiency, A-TOMO significantly reduced the time required for treatment planning to approximately 20 minutes.
Conclusion
We have successfully developed an A-TOMO planning method for cervical cancer.
Compared to M-TOMO plans, A-TOMO plans improved target conformity and reduced radiation dose to OARs.
Additionally, the quality of A-TOMO plans was on par with or surpasses that of A-VMAT plans.
The A-TOMO planning method significantly improved the efficiency of treatment planning.
Related Results
Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis
Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis
BackgroundDespite a remarkable progress in the reduction of global rate of maternal mortality, cervical cancer has been identified as the leading cause of maternal morbidity and mo...
SU‐FF‐T‐08: Tomotherapy Megavoltage Imaging for Gynecological Brachytherapy Treatment Planning and IMRT Integration
SU‐FF‐T‐08: Tomotherapy Megavoltage Imaging for Gynecological Brachytherapy Treatment Planning and IMRT Integration
Purpose: To demonstrate the use of the Tomotherapy IMRT system to image the standard shielded Fletcher‐Suit applicator for CT based brachytherapy dose calculations and to integrate...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Uptake and determinants of cervical cancer prevention services among female college students in Kenya: A cross-sectional survey
Uptake and determinants of cervical cancer prevention services among female college students in Kenya: A cross-sectional survey
Abstract
Introduction
Cervical cancer is the leading cause of cancer death in women in low- and middle-income countries. In Ken...
Cervical Cancer or Cervical Endometriosis – Review and Case Report
Cervical Cancer or Cervical Endometriosis – Review and Case Report
According to cancer death rates for women worldwide, this form of cancer ranks fourth after breast, bronchopulmonary, and colorectal cancer, affecting around 570,000 women annually...
C/EBPβ expression decreases in cervical cancer and leads to tumorigenesis
C/EBPβ expression decreases in cervical cancer and leads to tumorigenesis
Abstract
Background
Cervical cancer is currently estimated to be the fourth most common cancer among women worldwide and the leading cause of cancer...
CERVICAL CANCER STATUS, KNOWLEDGE, ATTITUDE AND ASSOCIATED FACTORS AMONG REPRODUCTIVE AGE WOMEN RESIDING IN HARGEISA, SOMALILAND
CERVICAL CANCER STATUS, KNOWLEDGE, ATTITUDE AND ASSOCIATED FACTORS AMONG REPRODUCTIVE AGE WOMEN RESIDING IN HARGEISA, SOMALILAND
Introduction: Cervical cancer results from a Human Papilloma Virus (HPV) infection. Seventy (70%) cervical cancers and pre-cancerous cervical lesions are attributed to HPV types 16...
Comparison of arc‐modulated cone beam therapy and helical tomotherapy for three different types of cancer
Comparison of arc‐modulated cone beam therapy and helical tomotherapy for three different types of cancer
Purpose:Arc‐modulated cone beam therapy (AMCBT) is a fast treatment technique deliverable in a single rotation with a conventional C‐arm shaped linac. In this planning study, the a...

